Taken together, our study reveals a new role of MDH2 in HCC ferroptosis and progression via regulating GPX4, and MDH2, which is highly expressed in HCC, may upregulate GPX4 to mediate ferroptosis evasion, leading to the failure of clinical cancer treatment. This evidence concerns the gene GPX4 and cancer.